Details for New Drug Application (NDA): 077250
✉ Email this page to a colleague
The generic ingredient in VIVACAINE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
Summary for 077250
Tradename: | VIVACAINE |
Applicant: | Septodont |
Ingredient: | bupivacaine hydrochloride; epinephrine bitartrate |
Patents: | 0 |
Pharmacology for NDA: 077250
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 077250
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VIVACAINE | bupivacaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 077250 | ANDA | Septodont, Inc. | 0362-0557 | 0362-0557-05 | 50 CARTRIDGE in 1 CARTON (0362-0557-05) / 1.8 mL in 1 CARTRIDGE |
VIVACAINE | bupivacaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 077250 | ANDA | Septodont, Inc. | 0362-9011 | 0362-9011-50 | 50 CARTRIDGE in 1 CARTON (0362-9011-50) / 1.8 mL in 1 CARTRIDGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.5%;0.0091MG/ML | ||||
Approval Date: | Sep 27, 2006 | TE: | RLD: | No |
Complete Access Available with Subscription